Referências

1. Huang S.N., Chen T.C., Tsai S.L., Et al., Histopathology and pathobiology of hepatotropic virus-induced liver injury, J Gastroenterol Hepatol, 12, pp. S195-S217, (1997)
2. Shimizu Y., Liver in systemic disease, World J Gastroenterol, 14, pp. 4111-4119, (2008)
3. Chand N., Sanyal A.J., Sepsis-induced cholestasis, Hepatology, 45, pp. 230-241, (2007)
4. Daniels D., Grytdal S., Wasley A., Surveillance for acute viral hepatitis-United States, 2007, MMWR Surveill Summ, 58, pp. 1-27, (2009)
5. Banait V.S., Sandur V., Parikh F., Et al., Outcome of acute liver failure due to acute hepatitis E in pregnant women, Indian J Gastroenterol, 26, pp. 6-10, (2007)
6. Aggarwal R., Naik S., Epidemiology of hepatitis E: current status, J Gastroenterol Hepatol, 24, pp. 1484-1493, (2009)
7. Schiodt F.V., Davern T.J., Shakil A.O., Et al., Viral hepatitis-related acute liver failure, Am J Gastroenterol, 98, pp. 448-453, (2003)
8. Elgouhari H.M., Abu-Rajab Tamimi T.I., Carey W.D., Hepatitis B virus infection: understanding its epidemiology, course, and diagnosis, Cleve Clin J Med, 75, pp. 881-889, (2008)
9. Seeff L.B., The history of the ""natural history"" of hepatitis C (1968-2009), Liver Int, 29, pp. 89-99, (2009)
10. Bianchi L., Liver biopsy interpretation in hepatitis. Part I. Presentation of critical morphologic features used in diagnosis (glossary), Pathol Res Pract, 178, pp. 2-19, (1983)
11. Lau J.Y., Xie X., Lai M.M., Et al., Apoptosis and viral hepatitis, Semin Liver Dis, 18, pp. 169-176, (1998)
12. Guzman M.G., Kouri G., Dengue: an update, Lancet Infect Dis, 2, pp. 33-42, (2002)
13. Gubler D.J., Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century, Trends Microbiol, 10, pp. 100-103, (2002)
14. Jessie K., Fong M.Y., Devi S., Et al., Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization, J Infect Dis, 189, pp. 1411-1418, (2004)
15. Groen J., Koraka P., Velzing J., Et al., Evaluation of six immunoassays for detection of dengue virus-specific immunoglobulin M and G antibodies, Clin Diagn Lab Immunol, 7, pp. 867-871, (2000)
16. Figueiredo L.T., Batista W.C., Kashima S., Et al., Identification of Brazilian flaviviruses by a simplified reverse transcription-polymerase chain reaction method using Flavivirus universal primers, Am J Trop Med Hyg, 59, pp. 357-362, (1998)
17. Zaki S.R., Greer P.W., Coffield L.M., Et al., Hantavirus pulmonary syndrome: pathogenesis of an emerging infectious disease, Am J Pathol, 146, pp. 552-579, (1995)
18. Vapalahti O., Mustonen J., Lundkvist A., Et al., Hantavirus infections in Europe, Lancet Infect Dis, 3, pp. 653-661, (2003)
19. Katz G., Williams R.J., Burt M.S., Et al., Hantavirus pulmonary syndrome in the State of Sao Paulo, Brazil, 1993-1998, Vector Borne Zoonotic Dis, 1, pp. 181-190, (2001)
20. Fischer R., Baumert T., Blum H.E., Hepatitis C virus infection and apoptosis, World J Gastroenterol, 13, pp. 4865-4872, (2007)
21. Dias L.B., Alves V.A., Kanamura C., Et al., Fulminant hepatic failure in northern Brazil: morphological, immunohistochemical and pathogenic aspects of Labrea hepatitis and yellow fever, Trans R Soc Trop Med Hyg, 101, pp. 831-839, (2007)
22. Boyer J.L., Klatskin G., Pattern of necrosis in acute viral hepatitis: prognostic value of bridging (subacute hepatic necrosis), N Engl J Med, 283, pp. 1063-1071, (1970)
23. Hanau C., Munoz S.J., Rubin R., Histopathological heterogeneity in fulminant hepatic failure, Hepatology, 21, pp. 345-351, (1995)
24. Scheuer P.J., Maggi G., Hepatic fibrosis and collapse: histological distinction by orcein staining, Histopathology, 4, pp. 487-490, (1980)
25. Theise N., Bodenheimer H.C., Ferrell L.D., Acute and chronic viral hepatitis, MacSween's Pathology of the Liver, pp. 399-441, (2007)
26. Fausto N., Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells, Hepatology, 39, pp. 1477-1487, (2004)
27. Kuo T.K., Hung S.P., Chuang C.H., Et al., Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells, Gastroenterology, 134, pp. 2111-2121, (2008)
28. Okuno T., Sano A., Deguchi T., Et al., Pathology of acute hepatitis A in humans. Comparison with acute hepatitis B, Am J Clin Pathol, 81, pp. 162-169, (1984)
29. Mushahwar I.K., Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention, J Med Virol, 80, pp. 646-658, (2008)
30. Acharya S.K., Panda S.K., Hepatitis E virus: epidemiology, diagnosis, pathology and prevention, Trop Gastroenterol, 27, pp. 63-68, (2006)
31. Peron J.M., Danjoux M., Kamar N., Et al., Liver histology in patients with sporadic acute hepatitis E: a study of 11 patients from South-West France, Virchows Arch, 450, pp. 405-410, (2007)
32. Smith J.L., A review of hepatitis E virus, J Food Prot, 64, pp. 572-586, (2001)
33. Ray M.B., Desmet V.J., Bradburne A.F., Et al., Differential distribution of hepatitis B surface antigen and hepatitis B core antigen in the liver of hepatitis B patients, Gastroenterology, 71, pp. 462-469, (1976)
34. Omata M., Iwama S., Sumida M., Et al., Clinico-pathological study of acute non-A, non-B post- transfusion hepatitis: histological features of liver biopsies in acute phase, Liver, 1, pp. 201-208, (1981)
35. Kobayashi K., Hashimoto E., Ludwig J., Et al., Liver biopsy features of acute hepatitis C compared with hepatitis A, B, and non-A, non-B, non-C, Liver, 13, pp. 69-72, (1993)
36. Johnson K., Kotiesh A., Boitnott J.K., Et al., Histology of symptomatic acute hepatitis C infection in immunocompetent adults, Am J Surg Pathol, 31, pp. 1754-1758, (2007)
37. Pessoa M.G., Alves V.A., Wakamatsu A., Et al., Post-transplant recurrent hepatitis C: immunohistochemical detection of hepatitis C virus core antigen and possible pathogenic implications, Liver Int, 28, pp. 807-813, (2008)
38. Rizzetto M., Canese M.G., Arico S., Et al., Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers, Gut, 18, pp. 997-1003, (1977)
39. Hsieh T.H., Liu C.J., Chen D.S., Et al., Natural course and treatment of hepatitis D virus infection, J Formos Med Assoc, 105, pp. 869-881, (2006)
40. Gomes-Gouvea M.S., Pereira Soares Mdo C., Guedes de Carvalho Mello I.M., Et al., Hepatitis D and B virus genotypes in chronically infected patients from the Eastern Amazon Basin, Acta Trop, 106, pp. 149-155, (2008)
41. Parana R., Kay A., Molinet F., Et al., HDV genotypes in the Western Brazilian Amazon region: a preliminary report, Am J Trop Med Hyg, 75, pp. 475-479, (2006)
42. Leite J.M., Morais M., Araujo R., Et al., Doença de Lábrea. Boletim do Centro de Estudos do Hospital dos Servidores do Estado, Rio de Janeiro, 18, pp. 170-172, (1966)
43. Fonseca J.C., Gayotto L.C., Ferreira L.C., Et al., Labrea hepatitis-hepatitis B and delta antigen expression in liver tissue: report of three autopsy cases, Rev Inst Med Trop Sao Paulo, 27, pp. 224-227, (1985)
44. Bensabath G., Hadler S.C., Soares M.C., Et al., Hepatitis delta virus infection and Labrea hepatitis: prevalence and role in fulminant hepatitis in the Amazon Basin, JAMA, 258, pp. 479-483, (1987)
45. Monath T.P., Yellow fever as an endemic/epidemic disease and priorities for vaccination, Bull Soc Pathol Exot, 99, pp. 341-347, (2006)
46. Farci P., Chessa L., Balestrieri C., Et al., Treatment of chronic hepatitis D, J Viral Hepat, 14, pp. 58-63, (2007)
47. Animal Viruses: Molecular Biology, (2008)
48. Stumpf M.P., Laidlaw Z., Jansen V.A., Herpes viruses hedge their bets, Proc Natl Acad Sci U S A, 99, pp. 15234-15237, (2002)
49. Petrova M., Muhtarova M., Nikolova M., Et al., Chronic Epstein-Barr virus-related hepatitis in immunocompetent patients, World J Gastroenterol, 12, pp. 5711-5716, (2006)
50. Markin R.S., Manifestations of Epstein-Barr virus-associated disorders in liver, Liver, 14, pp. 1-13, (1994)
51. Sanchez F., Gimeno-Bayon J.L., Esgueva R., Et al., Fatal liver failure: molecular evidence for chronic active Epstein-Barr virus infection, Ann Diagn Pathol, 12, pp. 368-371, (2008)
52. Koch D.G., Christiansen L., Lazarchick J., Et al., Posttransplantation lymphoproliferative disorder-the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of Epstein-Barr virus, Liver Transpl, 13, pp. 904-912, (2007)
53. Suh N., Liapis H., Misdraji J., Et al., Epstein-Barr virus hepatitis: diagnostic value of in situ hybridization, polymerase chain reaction, and immunohistochemistry on liver biopsy from immunocompetent patients, Am J Surg Pathol, 31, pp. 1403-1409, (2007)
54. Ho M., The history of cytomegalovirus and its diseases, Med Microbiol Immunol, 197, pp. 65-73, (2008)
55. Samuel D., Dussaix E., Cytomegalovirus infection, fulminant hepatitis, and liver transplantation: the sides of the triangle, Liver Transpl Surg, 3, pp. 547-551, (1997)
56. Parra Ruiz J., Pena Monje A., Tomas Jimenez C., Et al., Clinical spectrum of fever of intermediate duration in the south of Spain, Eur J Clin Microbiol Infect Dis, 27, pp. 993-995, (2008)
57. Hubscher S.G., Transplantation pathology, Semin Liver Dis, 29, pp. 74-90, (2009)
58. Lautenschlager I., Halme L., Hockerstedt K., Et al., Cytomegalovirus infection of the liver transplant: virological, histological, immunological, and clinical observations, Transpl Infect Dis, 8, pp. 21-30, (2006)
59. Limaye A.P., Bakthavatsalam R., Kim H.W., Et al., Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxis, Transplantation, 81, pp. 1645-1652, (2006)
60. Lu D.Y., Qian J., Easley K.A., Et al., Automated in situ hybridization and immunohistochemistry for cytomegalovirus detection in paraffin-embedded tissue sections, Appl Immunohistochem Mol Morphol, 17, pp. 158-164, (2009)
61. Zheng Z.B., Wu Y.D., Yu X.L., Et al., DNA microarray technology for simultaneous detection and species identification of seven human herpes viruses, J Med Virol, 80, pp. 1042-1050, (2008)
62. Halwachs-Baumann G., Recent developments in human cytomegalovirus diagnosis, Expert Rev Anti Infect Ther, 5, pp. 427-439, (2007)
63. Zerr D.M., Human herpesvirus 6: a clinical update, Herpes, 13, pp. 20-24, (2006)
64. Li D.Y., Boitnott J.B., Schwarz K.B., Human herpes virus-6 (HHV-6): a cause for fulminant hepatic failure or an ""innocent bystander""?, J Pediatr Gastroenterol Nutr, 37, (2003)
65. Levitsky J., Kalil A., Meza J.L., Et al., Herpes zoster infection after liver transplantation: a case-control study, Liver Transpl, 11, pp. 320-325, (2005)
66. Herrero J.I., Quiroga J., Sangro B., Et al., Herpes zoster after liver transplantation: incidence, risk factors, and complications, Liver Transpl, 10, pp. 1140-1143, (2004)
67. Azwa A., Barton S.E., Aspects of herpes simplex virus: a clinical review, J Fam Plann Reprod Health Care, 35, pp. 237-242, (2009)
68. Slifkin M., Doron S., Snydman D.R., Viral prophylaxis in organ transplant patients, Drugs, 64, pp. 2763-2792, (2004)
69. McQuillan G.M., Kruszon-Moran D., Granade T., Feldman J.W., Seroprevalence of human immunodeficiency virus in the US household population aged 18-49 years: the National Health and Nutrition Examination surveys, 1999-2006, J Acquir Immune Defic Syndr, (2009)
70. Levitsky J., Duddempudi A.T., Lakeman F.D., Et al., Detection and diagnosis of herpes simplex virus infection in adults with acute liver failure, Liver Transpl, 14, pp. 1498-1504, (2008)
71. Jacques S.M., Qureshi F., Herpes simplex virus hepatitis in pregnancy: a clinicopathologic study of three cases, Hum Pathol, 23, pp. 183-187, (1992)
72. Goodman Z.D., Ishak K.G., Sesterhenn I.A., Herpes simplex hepatitis in apparently immunocompetent adults, Am J Clin Pathol, 85, pp. 694-699, (1986)
73. Kelly N.P., Raible M.D., Husain A.N., Pathologic quiz case: an 11-day-old boy with lethargy, jaundice, fever, and melena, Arch Pathol Lab Med, 124, pp. 469-470, (2000)
74. Bissig K.D., Zimmermann A., Bernasch D., Et al., Herpes simplex virus hepatitis 4 years after liver transplantation, J Gastroenterol, 38, pp. 1005-1008, (2003)
75. Pinna A.D., Rakela J., Demetris A.J., Et al., Five cases of fulminant hepatitis due to herpes simplex virus in adults, Dig Dis Sci, 47, pp. 750-754, (2002)
76. Norvell J.P., Blei A.T., Jovanovic B.D., Et al., Herpes simplex virus hepatitis: an analysis of the published literature and institutional cases, Liver Transpl, 13, pp. 1428-1434, (2007)
77. Russell K.L., Hawksworth A.W., Ryan M.A., Et al., Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004, Vaccine, 24, pp. 2835-2842, (2006)
78. Nazir S.A., Metcalf J.P., Innate immune response to adenovirus, J Investig Med, 53, pp. 292-304, (2005)
79. Jalal H., Bibby D.F., Tang J.W., Et al., First reported outbreak of diarrhea due to adenovirus infection in a hematology unit for adults, J Clin Microbiol, 43, pp. 2575-2580, (2005)
80. Ison M.G., Adenovirus infections in transplant recipients, Clin Infect Dis, 43, pp. 331-339, (2006)
81. Emovon O.E., Chavin J., Rogers K., Et al., Adenovirus in kidney transplantation: an emerging pathogen?, Transplantation, 77, pp. 1474-1475, (2004)
82. Carrigan D.R., Adenovirus infections in immunocompromised patients, Am J Med, 102, pp. 71-74, (1997)
83. Pehler-Harrington K., Khanna M., Waters C.R., Et al., Rapid detection and identification of human adenovirus species by adenoplex, a multiplex PCR-enzyme hybridization assay, J Clin Microbiol, 42, pp. 4072-4076, (2004)
84. Zhang Y., Guo Y., Wu K., Et al., HPLC analysis of main flavonoid chemicals and their spatio-temporal dynamics in Bt transgenic cotton, Ying Yong Sheng Tai Xue Bao, 14, pp. 246-248, (2003)
85. Bertheau P., Parquet N., Ferchal F., Et al., Fulminant adenovirus hepatitis after allogeneic bone marrow transplantation, Bone Marrow Transplant, 17, pp. 295-298, (1996)
86. Torok T.J., Parvovirus B19 and human disease, Adv Intern Med, 37, pp. 431-455, (1992)
87. Yoto Y., Kudoh T., Haseyama K., Et al., Human parvovirus B19 infection associated with acute hepatitis, Lancet, 347, pp. 868-869, (1996)
88. Langnas A.N., Markin R.S., Cattral M.S., Et al., Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia, Hepatology, 22, pp. 1661-1665, (1995)
89. Sokal E.M., Melchior M., Cornu C., Et al., Acute parvovirus B19 infection associated with fulminant hepatitis of favourable prognosis in young children, Lancet, 352, pp. 1739-1741, (1998)
90. Yamamoto T., Ise K., Nakashima K., Et al., Parvovirus B19 as a trigger for spontaneous bacterial peritonitis in a patient with cirrhotic ascites, Am J Gastroenterol, 91, pp. 1857-1859, (1996)
91. Pinho J.R., Alves V.A., Vieira A.F., Et al., Detection of human parvovirus B19 in a patient with hepatitis, Braz J Med Biol Res, 34, pp. 1131-1138, (2001)
92. Monath T.P., Dengue and yellow fever-challenges for the development and use of vaccines, N Engl J Med, 357, pp. 2222-2225, (2007)
93. Peres L.C., Saggioro F.P., Dias L.B., Et al., Infectious diseases in paediatric pathology: experience from a developing country, Pathology, 40, pp. 161-175, (2008)
94. Quaresma J.A., Barros V.L., Fernandes E.R., Et al., Reconsideration of histopathology and ultrastructural aspects of the human liver in yellow fever, Acta Trop, 94, pp. 116-127, (2005)
95. Vieira W.T., Gayotto L.C., de Lima C.P., Et al., Histopathology of the human liver in yellow fever with special emphasis on the diagnostic role of the Councilman body, Histopathology, 7, pp. 195-208, (1983)
96. Gould E.A., Solomon T., Pathogenic flaviviruses, Lancet, 371, pp. 500-509, (2008)
97. Bae H.G., Nitsche A., Teichmann A., Et al., Detection of yellow fever virus: a comparison of quantitative real-time PCR and plaque assay, J Virol Methods, 110, pp. 185-191, (2003)
98. Hall W.C., Crowell T.P., Watts D.M., Et al., Demonstration of yellow fever and dengue antigens in formalin-fixed paraffin-embedded human liver by immunohistochemical analysis, Am J Trop Med Hyg, 45, pp. 408-417, (1991)
99. De Brito T., Siqueira S.A., Santos R.T., Et al., Human fatal yellow fever: immunohistochemical detection of viral antigens in the liver, kidney and heart, Pathol Res Pract, 188, pp. 177-181, (1992)
100. Vasconcelos P.F., Luna E.J., Galler R., Et al., Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases, Lancet, 358, pp. 91-97, (2001)
101. Martin M., Tsai T.F., Cropp B., Et al., Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases, Lancet, 358, pp. 98-104, (2001)
102. Galler R., Pugachev K.V., Santos C.L., Et al., Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil, Virology, 290, pp. 309-319, (2001)
103. Dengue Haemorrhagic Fever Diagnosis, Treatment, Prevention and Control, (1997)
104. Halstead S.B., Dengue in the Americas and Southeast Asia: do they differ?, Rev Panam Salud Publica, 20, pp. 407-415, (2006)